IBCIC

Our mission is to foster worldwide awareness, education, research and advocacy for #InflammatoryBreastCancer (IBC). #BCSM

[Duke Consortium for Inflammatory Breast Cancer @4dukeibc]

https://t.co/RYILJH1f9T

[IBCIC @IBC_Consortium]

Meet Our Organizing Committee!!
2nd International Workshop on #InflammatoryBreastCancer in Africa & 8th Ariana's Oncoday
Deadline for Abstract Submission: March 31st, 2025 -- https://t.co/Dpz4ulHERB
#metastaticbreastcancer #raredisease #breastcancer #triplenegativebreastcancer

[IBCIC @IBC_Consortium]

Meet Our Team! (Part I)

2nd International Workshop on #InflammatoryBreastCancer in Africa & 8th Ariana's Oncoday

Deadline for Abstract Submission: March 31st, 2025
#metastaticbreastcancer #raredisease #breastcancer #triplenegativebreastcancer

[IBCIC @IBC_Consortium]

We are pleased to announce our Key Speakers of the 3rd Session “Patient advocacy in IBC debates” of the 2nd International Workshop on Inflammatory Breast Cancer in Africa, along with the 8th Ariana’s Oncoday.
Abstract submission: March 31st, 2025 https://t.co/Dpz4ulIcH9

[IBCIC @IBC_Consortium]

We are excited to announce our Key Speakers for the 2nd Session of the 2nd International Workshop on Inflammatory Breast Cancer in Africa, along with the 8th Ariana’s Oncoday.

For more information, including registration and abstract submission: https://t.co/Dpz4ulHERB

[IBCIC @IBC_Consortium]

Excited to announce our Key Speakers of the 1st Session of the 2nd International Workshop on Inflammatory Breast Cancer in Africa, along with the 8th Ariana’s Oncoday. This event will be held on May 9th-10th, 2025, at the Carthage Thalasso Resort Hotel in Tunis, Tunisia

[IBCIC @IBC_Consortium]

2nd Workshop on #InflammatoryBreastCancer in Africa, May 9-10, 2025!! @MCristofanill @boussen2011 @MarwaManai3

[IBCIC @IBC_Consortium]

Today, we recognize National #MetastaticBreastCancer Awareness Day. Many #InflammatoryBreastCancer cancer patients are diagnosed as #StageIV because IBC usually develops quickly & spreads aggressively to other parts of the body. #EarlyDetection and a proper diagnosis is vital!

[IBCIC @IBC_Consortium]

We are proud to see our 2022 Early Career Investigator @MarwaManai3 presenting her awarded project, "Targeting MARCKS in #InflammatoryBreastCancer" at #ICCO23 in Tunisia, Africa. @boussen2011 @MCristofanill

[IBCIC @IBC_Consortium]

We have opened up an RFP for 2023 for the IBC-IC-Lieberman Family Early Career Investigator's Award.  The deadline date to submit a Letter of Intent (LOI) is October 9, 2023. 
Applicants should email their LOIs to [email protected]. @MCristofanill

[IBCIC @IBC_Consortium]

Join our IBC-IC Board Member Dr. Gayathri Devi this afternoon! @4dukeibc

[Duke Cancer @DukeCancer]

Looking forward to Dr. Gayathri Devi’s talk “Embracing Equity, Diversity and Inclusion (EDI): A Key to Effective Leadership” at @TheEndoSociety #ENDO2023. Dr. Devi also is chair of the Mentoring Committee w/ @Women_in_Endo.

Meet Dr. Devi: https://t.co/7ZfciCQKqo

@4dukeibc

[Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 @FilipaLynce]

@Nature_NPJ @IBC_DanaFarber Important data to help us learn more about HER2+ IBC. Thank you to all the patients who over the years agreed to be part of the @IBC_DanaFarber registry and are tremendously contributing to move the field forward. @DFCI_BreastOnc @TalkIBC @IBCResearch @IBC_Consortium

[Cristofanilli CTC Laboratory @CtcLaboratory]

Prognostic value of tumor-derived extracellular vesicles (#tdEVs) and circulating tumor cell (#CTCs) in #MetastaticBreastCancer: A focus on #InflammatoryBreastCancer @eleonora_nicolo @MCristofanill @WCMBreastCenter @WCM_MeyerCancer @NorthwesternMed @IEOufficiale

[Dr. Amy C. Moore @acmoorephd]

"Patients should receive our empathy, our humanity and our best care no matter how they made their way to the clinic" - Dr Eric Winer #endstigma #ASCO23

[IBCIC @IBC_Consortium]

Every #InflammatoryBreastCancer Patient says, "YES!"

[Elizabeth A. Mittendorf, MD, PhD, MHCM, FASCO @ASCOPres]

The question is what have I learned from this chronicle that could be helpful to all of you, and more specifically, how does my experience contribute to our collective understanding of partnerships between patients and clinicians in oncology? I have some thoughts.... 1/4 #ASCO23

[IBCIC @IBC_Consortium]

Helpful tool for our #InflammatoryBreastCancer Patient #Advocates at @ASCO

[Dr. Amy C. Moore @acmoorephd]

Are you a patient #advocate at #ASCO23 and struggling to understand what all those lines and colors mean? Here is an overview that may help you as you listen to talks and look at posters: https://t.co/bjhqOmjc5S @IASLC #STARS

[IBCIC @IBC_Consortium]

We ask our #IBC #cancer community to send letters to their legislators calling on them to address current #drugshortages that are negatively impacting our community. For many, it's a matter of life and death. Please take a few seconds to reach out!
https://t.co/PP2URC12lh

[Duke Consortium for Inflammatory Breast Cancer @4dukeibc]

The Devi Laboratory congratulates IBC trainees Alex Bennion and Kush Gulati on their graduation from Duke University! @DukeCancer @Duke_CTSI @TerryLynnArnold @ACSCAN @DukeSurgery @DukeTrinity @DukeEngineering @DukeAPPLI @DukePathDept @DukeBiology

[Duke Consortium for Inflammatory Breast Cancer @4dukeibc]

IBC Trainees in Dr. Gayathri Devi’s laboratory celebrate the last day of independent study research and classes. @DukeCancer @DukeSurgery @AmericanCancer @TalkIBC @DukeMedSchool @Duke_CTSI @IBC_Consortium @DukeTrinity @DukeEngineering

[IBCIC @IBC_Consortium]

We want to announce that the voting polls closed last week for the "People's Choice" Session for @SABCSSanAntonio 2023, & our “#InflammatoryBreastCancer" topic/proposal was chosen with the most votes for the 2 hr session. Thank you all for spreading the word and voting!